Increased angiogenic growth factor in cyanotic congenital heart disease

W. Himeno, Teiji Akagi, J. Furui, Y. Maeno, M. Ishii, K. Kosai, T. Murohara, H. Kato

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

To examine the relationship between the plasma levels of angiogenic growth factors and the severity of cyanosis, 80 patients with cyanotic heart disease (CHD) and 81 healthy controls were studied. Median age and mean arterial blood oxygen saturation respectively were 4.2 years and 81% in CHD subjects and 4.8 years and 98% in controls. Vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) were measured in plasma using enzyme-linked immunoassay. Plasma VEGF levels in controls depended negatively on age (p <0.0001) until 3 months, when VEGF was no longer elevated. No such age dependence was found for HGF. Although VEGF levels did not differ between CHD and control subjects up to the age of 3 months, VEGF was significantly elevated in CHD patients older than 3 months compared to controls of similar age (149 ± 106 vs 65 ± 23 pg/ml, p <0.0001). Moreover, the VEGF levels were negatively correlated with oxygen saturation (p = 0.03) and positively correlated with hemoglobin (p = 0.004) in CHD patients aged between 3 months and 10 years. Although the physiologic elevation of VEGF in the neonatal period decreases rapidly if oxygen saturation is normal, VEGF elevations persist if systemic hypoxia is present.

Original languageEnglish
Pages (from-to)127-132
Number of pages6
JournalPediatric Cardiology
Volume24
Issue number2
DOIs
Publication statusPublished - Mar 2003
Externally publishedYes

Fingerprint

Angiogenesis Inducing Agents
Vascular Endothelial Growth Factor A
Heart Diseases
Intercellular Signaling Peptides and Proteins
Hepatocyte Growth Factor
Oxygen
Cyanosis
Immunoenzyme Techniques
Hemoglobins

Keywords

  • Angiogenesis
  • Hepatocyte growth factor
  • Hypoxia
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pediatrics, Perinatology, and Child Health

Cite this

Himeno, W., Akagi, T., Furui, J., Maeno, Y., Ishii, M., Kosai, K., ... Kato, H. (2003). Increased angiogenic growth factor in cyanotic congenital heart disease. Pediatric Cardiology, 24(2), 127-132. https://doi.org/10.1007/s00246-002-0266-5

Increased angiogenic growth factor in cyanotic congenital heart disease. / Himeno, W.; Akagi, Teiji; Furui, J.; Maeno, Y.; Ishii, M.; Kosai, K.; Murohara, T.; Kato, H.

In: Pediatric Cardiology, Vol. 24, No. 2, 03.2003, p. 127-132.

Research output: Contribution to journalArticle

Himeno, W, Akagi, T, Furui, J, Maeno, Y, Ishii, M, Kosai, K, Murohara, T & Kato, H 2003, 'Increased angiogenic growth factor in cyanotic congenital heart disease', Pediatric Cardiology, vol. 24, no. 2, pp. 127-132. https://doi.org/10.1007/s00246-002-0266-5
Himeno, W. ; Akagi, Teiji ; Furui, J. ; Maeno, Y. ; Ishii, M. ; Kosai, K. ; Murohara, T. ; Kato, H. / Increased angiogenic growth factor in cyanotic congenital heart disease. In: Pediatric Cardiology. 2003 ; Vol. 24, No. 2. pp. 127-132.
@article{4ddcdb20497441828512fc00ec345bf9,
title = "Increased angiogenic growth factor in cyanotic congenital heart disease",
abstract = "To examine the relationship between the plasma levels of angiogenic growth factors and the severity of cyanosis, 80 patients with cyanotic heart disease (CHD) and 81 healthy controls were studied. Median age and mean arterial blood oxygen saturation respectively were 4.2 years and 81{\%} in CHD subjects and 4.8 years and 98{\%} in controls. Vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) were measured in plasma using enzyme-linked immunoassay. Plasma VEGF levels in controls depended negatively on age (p <0.0001) until 3 months, when VEGF was no longer elevated. No such age dependence was found for HGF. Although VEGF levels did not differ between CHD and control subjects up to the age of 3 months, VEGF was significantly elevated in CHD patients older than 3 months compared to controls of similar age (149 ± 106 vs 65 ± 23 pg/ml, p <0.0001). Moreover, the VEGF levels were negatively correlated with oxygen saturation (p = 0.03) and positively correlated with hemoglobin (p = 0.004) in CHD patients aged between 3 months and 10 years. Although the physiologic elevation of VEGF in the neonatal period decreases rapidly if oxygen saturation is normal, VEGF elevations persist if systemic hypoxia is present.",
keywords = "Angiogenesis, Hepatocyte growth factor, Hypoxia, Vascular endothelial growth factor",
author = "W. Himeno and Teiji Akagi and J. Furui and Y. Maeno and M. Ishii and K. Kosai and T. Murohara and H. Kato",
year = "2003",
month = "3",
doi = "10.1007/s00246-002-0266-5",
language = "English",
volume = "24",
pages = "127--132",
journal = "Pediatric Cardiology",
issn = "0172-0643",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Increased angiogenic growth factor in cyanotic congenital heart disease

AU - Himeno, W.

AU - Akagi, Teiji

AU - Furui, J.

AU - Maeno, Y.

AU - Ishii, M.

AU - Kosai, K.

AU - Murohara, T.

AU - Kato, H.

PY - 2003/3

Y1 - 2003/3

N2 - To examine the relationship between the plasma levels of angiogenic growth factors and the severity of cyanosis, 80 patients with cyanotic heart disease (CHD) and 81 healthy controls were studied. Median age and mean arterial blood oxygen saturation respectively were 4.2 years and 81% in CHD subjects and 4.8 years and 98% in controls. Vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) were measured in plasma using enzyme-linked immunoassay. Plasma VEGF levels in controls depended negatively on age (p <0.0001) until 3 months, when VEGF was no longer elevated. No such age dependence was found for HGF. Although VEGF levels did not differ between CHD and control subjects up to the age of 3 months, VEGF was significantly elevated in CHD patients older than 3 months compared to controls of similar age (149 ± 106 vs 65 ± 23 pg/ml, p <0.0001). Moreover, the VEGF levels were negatively correlated with oxygen saturation (p = 0.03) and positively correlated with hemoglobin (p = 0.004) in CHD patients aged between 3 months and 10 years. Although the physiologic elevation of VEGF in the neonatal period decreases rapidly if oxygen saturation is normal, VEGF elevations persist if systemic hypoxia is present.

AB - To examine the relationship between the plasma levels of angiogenic growth factors and the severity of cyanosis, 80 patients with cyanotic heart disease (CHD) and 81 healthy controls were studied. Median age and mean arterial blood oxygen saturation respectively were 4.2 years and 81% in CHD subjects and 4.8 years and 98% in controls. Vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) were measured in plasma using enzyme-linked immunoassay. Plasma VEGF levels in controls depended negatively on age (p <0.0001) until 3 months, when VEGF was no longer elevated. No such age dependence was found for HGF. Although VEGF levels did not differ between CHD and control subjects up to the age of 3 months, VEGF was significantly elevated in CHD patients older than 3 months compared to controls of similar age (149 ± 106 vs 65 ± 23 pg/ml, p <0.0001). Moreover, the VEGF levels were negatively correlated with oxygen saturation (p = 0.03) and positively correlated with hemoglobin (p = 0.004) in CHD patients aged between 3 months and 10 years. Although the physiologic elevation of VEGF in the neonatal period decreases rapidly if oxygen saturation is normal, VEGF elevations persist if systemic hypoxia is present.

KW - Angiogenesis

KW - Hepatocyte growth factor

KW - Hypoxia

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=0043246491&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0043246491&partnerID=8YFLogxK

U2 - 10.1007/s00246-002-0266-5

DO - 10.1007/s00246-002-0266-5

M3 - Article

C2 - 12360391

AN - SCOPUS:0043246491

VL - 24

SP - 127

EP - 132

JO - Pediatric Cardiology

JF - Pediatric Cardiology

SN - 0172-0643

IS - 2

ER -